In adult New Zealand white rabbits with SCI/R, a design comparing 2 mg/kg NS 309 with vehicle found no significant differences in blood pH, PaO2, PaCO2, or glucose among all groups. Following intraperitoneal administration of 2 mg/kg NS 309 at spinal cord ischemia initiation, the NS 309 group had more normal motor neurons than the vehicle group at 72 h after reperfusion. [2]
Blood measurements in rabbits with SCI/R
Animal study · Adult New Zealand white rabbits (2.5–3.0 kg); SCI/R [2]
Adult New Zealand white rabbits with SCI/R received NS 309 at 2 mg/kg or vehicle. No significant differences in blood pH, PaO2, PaCO2, or glucose were observed among all groups.
- NS 309 2 mg/kg
- Model: Adult New Zealand white rabbits (2.5–3.0 kg); SCI/R
- Reported limits: Not stated in the sentences used: route, schedule, vehicle.
Methods and source locations
Compound reported in the paper: NS 309
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Animals and Agents (S1); Materials and Methods > SCI/R Model (S7, S10); Results > SCI/R Decreases the Expression of SK/KCa1 Subtype (S59, S60); Table 2 (T2.h1, T2.r4, T2.r5, T2.r6, T2.r7, T2.r8, T2.r9)
PaO2; 10 min after ischemia; 10 min after reperfusion: PaO2; 10 min after ischemia; 10 min after reperfusion; comparator: Vehicle — Results > SCI/R Decreases the Expression of SK/KCa1 Subtype (S60); Table 2 (T2.h1, T2.r4, T2.r6, T2.r7, T2.r9)
NS 309 2 mg/kg · Results > SCI/R Decreases the Expression of SK/KCa1 Subtype (S59, S60); Table 2 (T2.h1, T2.r6, T2.r9)
Normal motor neurons after spinal cord ischemia and reperfusion
Animal study · Adult New Zealand white rabbits (2.5–3.0 kg); SCI/R; n = 8 [2]
Adult New Zealand white rabbits with SCI/R received 2 mg/kg NS 309 by intraperitoneal injection at spinal cord ischemia initiation. At 72 h after reperfusion, the NS 309 group had more normal motor neurons than the vehicle group.
Conditions shared by the study groups
- Route
- intraperitoneal injection
- Treatment course
- at the time of spinal cord ischemia initiation
- NS 309 2 mg/kg
- Model: Adult New Zealand white rabbits (2.5–3.0 kg); SCI/R; n = 8
- Reported limits: Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: NS 309
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Animals and Agents (S1); Materials and Methods > SCI/R Model (S7, S10); Materials and Methods > Experimental Design > Experimental 2 (S17, S18); Results > The SK/KCa Channel Activator NS309 Protects Against SCI/R (S69); FIGURE 2 legend (S104, S108)
number of normal motor neurons; at 72 h after reperfusion: number of normal motor neurons; at 72 h after reperfusion; comparator: saline (0.9%) with 1% DMSO — Results > The SK/KCa Channel Activator NS309 Protects Against SCI/R (S69); FIGURE 2 legend (S104)
NS 309 2 mg/kg · Materials and Methods > Experimental Design > Experimental 2 (S18); Results > The SK/KCa Channel Activator NS309 Protects Against SCI/R (S69)